Marin C - Search Results

1

Short- and long-term effects induced by repeated 6-OHDA intraventricular administration: A new progressive and bilateral rodent model of Parkinson's disease.

Quiroga-Varela A, Aguilar E, Iglesias E, Obeso JA, Marin C. Quiroga-Varela A, et al. Among authors: marin c. Neuroscience. 2017 Oct 11;361:144-156. doi: 10.1016/j.neuroscience.2017.08.017. Epub 2017 Aug 18. Neuroscience. 2017. PMID: 28823819

2

Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.

Marin C, Aguilar E, Bonastre M, Tolosa E, Obeso JA. Marin C, et al. Exp Neurol. 2005 Mar;192(1):184-93. doi: 10.1016/j.expneurol.2004.10.008. Exp Neurol. 2005. PMID: 15698633

3

Concomitant short- and long-duration response to levodopa in the 6-OHDA-lesioned rat: a behavioural and molecular study.

Marin C, Aguilar E, Mengod G, Cortés R, Obeso JA. Marin C, et al. Eur J Neurosci. 2007 Jan;25(1):259-69. doi: 10.1111/j.1460-9568.2006.05265.x. Eur J Neurosci. 2007. PMID: 17241287

4

Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes.

Marin C, Aguilar E, Mengod G, Cortés R, Rodríguez-Oroz MC, Obeso JA. Marin C, et al. Neurobiol Dis. 2008 Dec;32(3):340-8. doi: 10.1016/j.nbd.2008.07.019. Epub 2008 Aug 5. Neurobiol Dis. 2008. PMID: 18722529 Free article.

5

Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats.

Marin C, Aguilar E, Rodríguez-Oroz MC, Bartoszyk GD, Obeso JA. Marin C, et al. Psychopharmacology (Berl). 2009 Jun;204(2):241-50. doi: 10.1007/s00213-008-1452-9. Epub 2009 Jan 22. Psychopharmacology (Berl). 2009. PMID: 19159919

6

Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats.

Marin C, Aguilar E, Mengod G, Cortés R, Obeso JA. Marin C, et al. Eur J Neurosci. 2009 Sep;30(5):823-32. doi: 10.1111/j.1460-9568.2009.06877.x. Epub 2009 Aug 27. Eur J Neurosci. 2009. PMID: 19712101

7

In vivo 6-OHDA-induced neurodegeneration and nigral autophagic markers expression.

Marin C, Aguilar E. Marin C, et al. Neurochem Int. 2011 Mar;58(4):521-6. doi: 10.1016/j.neuint.2011.01.010. Epub 2011 Jan 13. Neurochem Int. 2011. PMID: 21237229

8

What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity.

Quiroga-Varela A, Walters JR, Brazhnik E, Marin C, Obeso JA. Quiroga-Varela A, et al. Among authors: marin c. Neurobiol Dis. 2013 Oct;58:242-8. doi: 10.1016/j.nbd.2013.05.010. Epub 2013 May 30. Neurobiol Dis. 2013. PMID: 23727447 Free PMC article. Review.

9

Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease.

Marin C, Bonastre M, Mengod G, Cortés R, Rodríguez-Oroz MC, Obeso JA. Marin C, et al. Exp Neurol. 2013 Dec;250:304-12. doi: 10.1016/j.expneurol.2013.10.006. Epub 2013 Oct 18. Exp Neurol. 2013. PMID: 24140562

10

Missing pieces in the Parkinson's disease puzzle.

Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G. Obeso JA, et al. Among authors: marin c. Nat Med. 2010 Jun;16(6):653-61. doi: 10.1038/nm.2165. Epub 2010 May 23. Nat Med. 2010. PMID: 20495568 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,026 results

Search Page

Filters